1 Diadenosine polyphosphates (Ap n As, n=2 ± 7) are considered as stress mediators in the cardiovascular system. They act both via identi®ed P2 purinoceptors and via yet to be characterized receptors. This study analyses the actions of Ap n As in clones of rat brain capillary endothelial cells that express P2Y 1 receptors (B10 cells) or both P2Y 1 and P2Y 2 receptors (B7 cells). 2 B10 cells responded to Ap 3 A with rises in intracellular Ca 2+ concentration ([Ca 2+ ] i ). This response was prevented by adenosine-3'-phosphate-5'-phosphate, an antagonist of P2Y 1 receptors. It was largely suppressed by a treatment with apyrase VII or with creatine phosphokinase/creatine phosphate to degrade contaminating ADP. 3 Ap n As inhibited ADP induced increases in [Ca 2+ ] i mediated by P2Y 1 receptors by shifting ADP concentration-response curves to larger concentrations. Apparent K i values were estimated to be 6 mM for Ap 4 A, 10 mM for Ap 5 A and 47 mM for Ap 6 A. Ap 2 A and Ap 3 A were much less active. 4 Ap n As were neither agonists nor antagonists of the endogenous P2Y 2 receptor in B7 cells. 
Introduction
Diadenosine polyphosphates (Ap n As, n=2 ± 7) form a group of compounds that consist of two adenosine molecules bridged by 2 ± 7 phosphate groups. They are stored in platelet dense granules, in chroman granules of the adrenal medulla, in Torpedo cholinergic vesicles and in rat brain synaptic terminals. Possible roles as neurotransmitters and stress signals have been proposed (Hoyle, 1990; Hoyle et al., 1996; Pintor et al., 1997) . Actions of Ap n As on the cardiovascular system have recently been reviewed (Flores et al., 1999) . Some of the compounds promote platelet aggregation, while others are inhibitory. Compounds with four or more phosphates are usually vasoconstrictors, while those with three or less phosphates are vasodilators (Ralevic et al., 1995) . Ap n As also produce marked cardiac electrophysiological eects (Flores et al., 1999) .
Ap n As are thought to act via known metabotropic and ionotropic purinoceptors of the P2 type. Ap 3 A was reported to be an agonist of the chick P2Y 1 receptor and of the human P2Y 2 receptor (Lazarowski et al., 1995) . Ap 4 A was reported to be an agonist of the chick, turkey and human P2Y 1 receptors Schachter et al., 1996) , of the human P2Y 2 receptor (Lazarowski et al., 1995) and of rat P2X 2 receptors . Results obtained with endogenous receptors are less clear. Ap 3 A and Ap 4 A have been reported to be either active or inactive at the P2Y 1 receptor depending on the cell line used (Chen et al., 1996; Conant et al., 1998; Mateo et al., 1996; Stachon et al., 1998) . Ap 4 A was reported to be inactive at endogenous P2Y 2 receptors (Chen et al., 1996; Conant et al., 1998; Mateo et al., 1996) . Dierent hypotheses may account for these con¯icting results. (i) Contamination of commercially available Ap n As by mononucleotides may lead to spurious responses (Conant et al., 1998) . (ii) P2 receptors may not have been correctly identi®ed in cell lines and tissues. (iii) Properties of the P2 receptors in recombinant expression systems may be dierent from those in tissues (Hechler et al., 1998b; Palmer et al., 1998) . (iv) Ap n As may act via receptors that are yet to be identi®ed .
This study analyses the actions of Ap n As in two clones of rat brain capillary endothelial cells: B7 and B10 cells. Previous results from this laboratory have shown that while B7 cells express mRNAs that code for P2Y 1 and P2Y 2 receptors, B10 cells only express P2Y 1 receptor transcripts (Feolde et al., 1995; Webb et al., 1996) . Nucleotides have two major actions in B7 and B10 cells. They induce a mobilization of intracellular Ca 2+ stores and inhibit cholera toxin stimulated adenylyl cyclase via a pertussis toxinsensitive, G i -mediated, mechanism (Frelin et al., 1993; Webb et al., 1996) . Detailed pharmacological analyses using additivity experiments, desensitization experiments and speci®c inhibitors of P2Y 1 receptors allowed us to attribute these responses to three types of receptors. Intracellular Ca 2+ rises ([Ca 2+ ] i ) in B10 cells have been attributed to the P2Y 1 receptor. ADP and 2-methyl-thio-ADP are agonists of this receptor. ATP and its derivatives, pyridoxal phosphate-6-azophenyl-2',4'-sulphonic acid (PPADS), adenosine-2'-phosphate-5'-phosphate (A2P5P) and adenosine-3'-phosphate-5'-phosphate (A3P5P) and their sulphate derivatives are antagonists (Vigne et al., 1998b; Hechler et al., 1998a) . [Ca 2+ ] i responses in B7 cells have been attributed to the P2Y 1 receptor and to an additional receptor that is speci®c for ATP and UTP on the basis of additivity and desensitization experiments (Frelin et al., 1993; Vigne et al., 1994) . This pharmacological pro®le and the observation that B7 cells express P2Y 2 receptor mRNAs suggest the presence of functional P2Y 2 receptors. The G i -coupled receptor in B10 cells was initially thought to be the P2Y 1 receptor (Webb et al., 1996) but this conclusion was challenged by more recent experiments using selective antagonists of the P2Y 1 receptors (Hechler et al., 1998b (Anwar et al., 1999) .
Methods

Cell culture
Rat brain capillary endothelial cells of the B7 and B10 clones were cultured as described previously . The culture medium was Dulbecco's modi®ed Eagle's medium supplemented with 10% foetal calf serum, 100 units ml 71 penicillin and 100 mg ml 71 streptomycin.
Intracellular Ca 2+ measurements
For intracellular Ca 2+ measurements, suspended cells were incubated for 30 min in the presence of 5 mM indo-1/AM, centrifuged at 10006g and resuspended into an Earle's salt solution (composition in mM): NaCl 140, KCl 5, CaCl 2 1.8, MgCl 2 0.8, glucose 5, HEPES 25, pH 7.4) at a density of 10 6 cells ml 71 . Nucleotides (10 ml) were added to test tubes and the reaction was initiated by adding 90 ml of the cell suspension. These conditions ensured that cells were exposed at the same time to agonists and antagonists. After mild vortexing, tubes were inserted into a FacStar Plus cytometer (Becton Dickinson) (Vigne et al., 1994) . Mean¯uorescence ratios were determined for 1000 cells sampled between 8 and 10 s after the addition of nucleotides. This time corresponded to the peak of the [Ca 2+ ] i transient (Vigne et al., 1994) . Fluorescence ratios were calculated in arbitrary units set to a value of 100 for unstimulated cells. This value takes into account the auto¯uorescence and the basal indo-1¯uorescence. Using these settings, ADP (1 mM) or UTP (0.1 mM, in B7 cells only) increased the indo-1¯uorescence ratio to 200 ± 250 arbitrary units. Responses were calculated as the dierence between the¯uorescence units observed in stimulated cells and those observed in control unstimulated cells. Means of triplicate measurements were used. Controls were included in each experimental protocol. All responses were expressed as a percentage of the response to 1 mM ADP, typically 100 ± 150 arbitrary units. Experiments were repeated at least three times using dierent batches of cells.
Adenylyl cyclase assays
B10 cells grown in 6-well tissue culture clusters were labelled with 1 mCi ml 71 of [ 3 H]-Adenine (Amersham, 26 Ci mmol 71 ) overnight in complete culture medium. The culture medium was then removed, cells were rinsed with an Earle's salt solution and further incubated into an Earle's salt solution supplemented with 0.1 mM isobutylmethylxanthine. After 10 min at 378C, cells were stimulated with 1 mM forskolin in the absence or the presence of diadenosine polyphosphates (0.1 mM) and or of ADP (5 mM). After 5 min, the incubation solution was aspirated o and the reaction was stopped by addition of 500 ml of ice cold 5% trichloracetic acid supplemented with 2 mM ATP and 2 mM cyclic AMP (used as carriers). After 15 min of extraction at 48C, cell extracts were harvested and the tritium label associated with cyclic AMP was determined using sequential chromatographies on Dowex and alumina columns (Bozou et al., 1986) . In some experiments a protein-binding assay (Immunotech, Marseille, France) was used.
Materials
Ap n As, adenosine-3'-phosphate-5'-phosphate, ADP, UTP, creatine, creatine phosphate, creatine phosphokinase (Type III from bovine heart), indo-1/AM, forskolin, isobutylmethylxanthine and apyrase VII were purchased from the Sigma Chemical Co. Reagents were dissolved into an Earle's salt solution. In some experiments it was necessary to purify solutions of Ap n As from contaminating ADP (see Results). Solutions of Ap 3 A and Ap 6 A (1 mM in Earle's salt solution) were treated for 20 min with 1 unit ml 71 apyrase VII or with a mixture of 20 units ml 71 creatine phosphokinase and 10 mM creatine phosphate. The mixture was then added to the cells without inactivation of the enzymes. We checked that these treatments abolished the Ca 2+ mobilizing action of a 10 mM solution of ADP. To remove trace contaminants of ATP, solutions of Ap n As were treated for 30 min with a mixture of 20 units ml 71 creatine phosphokinase and 10 mM creatine.
Curve ®tting and statistical analysis
Curves were ®tted with a logistic equation using the SigmaPlot software (Jandel Scienti®cs). Mean+s.e.mean from n indepen- ] i in B10 cells. Indo-1 loaded cells were incubated in the presence of 0.1 mM Ap n A or of 1 mM ADP and 0.1 mM Ap n As and mean indo-1¯uorescence ratio were recorded at 10 s. Means+s.e.mean (n=3) are shown. Increases in indo-1 uorescence ratio were expressed relative to that produced by 1 mM ADP. *P50.05 and **P50.01 as compared to controls. n on the abscissa means the number of phosphate groups in the Ap n As tested. dent experiments are indicated. Statistical analysis was performed by use of Student's t-test.
Results
Actions of Ap n As on [Ca 2+ ] i in B10 cells
Actions of Ap n As on intracellular Ca 2+ were analysed using indo-1 loaded B10 cells. Figure 1 shows that only Ap 3 A and Ap 6 A increased [Ca 2+ ] i in B10 cells. Ca 2+ transients induced by Ap 3 A had the same shape and time course as ADP-induced Ca 2+ transients and were largely independent of the presence of extracellular Ca 2+ (data not shown). The ecacy of 0.1 mM Ap 3 A was only 44% that of 1 mM ADP, the natural agonist of P2Y 1 receptors (Figure 1 ). Actions of Ap 3 A were prevented by 0.1 mM A3P5P, an antagonist of P2Y 1 receptors. They were also highly variable from one batch of compound to the other. These suggested that the [Ca 2+ ] i responses to Ap 3 A could be due to contaminating ADP. Considering that a concentration of 0.7 mM ADP induced half maximum activation of P2Y 1 receptors in B10 cells (see below), it can be calculated that the [Ca 2+ ] i rise induced by 0.1 mM Ap 3 A could be accounted for by only a 0.2% contamination of Ap 3 A by ADP. To check the hypothesis that actions of Ap 3 A were due to contaminant ADP, solutions of Ap 3 A were treated with ADP degrading enzymes. Creatine phosphokinase (in the presence of creatine phosphate) decreased the ecacy of 0.1 mM Ap 3 A from 44 to 10% that of 0.1 mM ADP. Conversely apyrase decreased the ecacy of 0.1 mM Ap 3 A from 44 to 7% that of 1 mM ADP. These results suggested that low amounts of ADP contaminated Ap 3 A solutions and were probably responsible for most of the observed rises in [Ca 2+ ] i . The action of 0.1 mM Ap 6 A which was at the limit of detectability was not investigated.
We next looked for possible antagonistic actions of Ap n As on P2Y 1 responses using ADP, the natural agonist of P2Y 1 receptors. The EC 50 value for the action of ADP was 0.7+0.1 mM (n=9) in this series of experiments. Cells were stimulated with a submaximally eective concentration of ADP (1 mM) in the presence of 0.1 mM and Ap n As. These experiments do not require the use of enzymatically puri®ed Ap n As for 1 mM ADP was already present in the assay medium to stimulate receptors. Figure 1 shows that all Ap n As inhibited the action of ADP. Inhibition was almost complete with Ap 4 A and Ap 5 A. Actions of Ap 2 A and Ap 3 A were not analysed. Figure 2A shows concentration-response curves for the action of ADP in the absence or the presence of Ap 4 A. Ap 4 A (0.1 mM) shifted the ADP concentration-response curve to larger concentrations without modifying the maximum ecacy of ADP. This suggested an apparent competitive mechanism. The 13 fold shift led us to calculate a pA 2 value for Ap 4 A of 5.9 corresponding to an apparent K i value of 8 mM. Figure 2B shows the concentration-response curve for the inhibition by Ap 4 A of ADP (1 mM) responses. In three independent experiments such as those presented in Figure 2B , the concentration of Ap 4 A that produced half-maximum inhibition of the action of ADP (IC 50 ) was 11.4+1.5 mM. An apparent K i value for Ap 4 A was deduced from the ChengPruso relationship:
Considering that K (ADP) was 0.7 mM, [ADP] was 1 mM and IC 50 was 11.4 mM, a K i value of 5 mM was calculated. It was close to the value found in the preceding experiment. Figure 3A shows that Ap 5 A (0.2 mM) shifted the ADP concentration-response curve to larger concentrations without modifying the maximum ecacy of ADP. The 16 fold increase in EC 50 value indicated a pA 2 value for Ap 5 A of 4.9 corresponding to an apparent K i value of 13 mM. Figure 3B shows the concentration-response curve for the inhibition by Ap 5 A of ADP (1 mM) responses. Half-maximum inhibition was observed at 20.0+1.6 mM Ap 5 A (n=3). Application of the Cheng-Pruso relationship led to an apparent K i value of 8 mM, close to the value found in the preceding experiment. Figure 4A shows that Ap 6 A (0.2 mM) shifted the ADP concentration-response curve to larger concentrations without modifying the maximum ecacy of ADP. The 9 fold increase in EC 50 value indicated a pA 2 value for Ap 6 A of 4.6 corresponding to an apparent K i value of 25 mM. Figure 4B shows the concentration-response curve for the inhibition by Ap 6 A of ADP responses. Half-maximum inhibition was observed at 168+14 mM Ap 6 A (n=3). Application of the Cheng-Pruso relationship led to an apparent K i value of 69 mM. A major diculty encountered with purinergic ligands is that actions measured could be due to other nucleotides present in commercial powders or produced for instance by cellular ecto-enzymes. We checked that AMP and adenosine (up to 1 mM) did not inhibit ADP responses in endothelial cells and were thus unlikely to mediate inhibitory actions of Ap 4 A, Ap 5 A and Ap 6 A. We also checked that puri®cation of Ap n A solutions from ATP using creatine phosphokinase and creatine did not modify the properties of antagonistic Ap n As. Taken together these indicated that inhibitory actions of Ap n As in endothelial cells were unlikely to be mediated by adenosine, AMP or ATP.
Actions of Ap n As in B7 cells
Identical experiments were performed using cells of the B7 clone. These cells were of interest because they express functional P2Y 2 receptors in addition to P2Y 1 receptors. Figure 5A shows that Ap 3 A and Ap 6 A induced increases in [Ca 2+ ] i that were of smaller amplitude than those induced by ADP. Other Ap n As were inactive. These actions were decreased to less than 10% of the amplitude of the ADP (1 mM) signal after enzymatic degradation of contaminating ADP using creatine phosphokinase or apyrase. Figure 5A further shows that Ap n As did not antagonize UTP responses. UTP and some Ap n As (Ap 3 A, Ap 5 A and Ap 6 A) had additive actions on [Ca 2+ ] i . The reasons for these dierences was not investigated. It could simply be due to the fact that UTP and a contaminant present in Ap n A solutions (presumably ADP) activated two independent receptors. Finally, Figure 5B shows that Ap 4 A blocked ADP-responses mediated by P2Y 1 receptors with properties similar to those observed in B10 cells. UTP responses were insensitive to Ap 4 A. These results indicate that Ap n As had neither agonistic nor antagonistic actions at the endogenous P2Y 2 receptor in B7 cells. 
Actions of Ap n As on adenylyl cyclase in B10 cells
Formation of cyclic AMP can be assessed either by protein binding assays or by following the conversion of [ 3 H]-ATP into [ 3 H]-cyclic AMP. The ®rst technique led us to the conclusion that Ap 4 A, Ap 5 A and Ap 6 A (at concentrations 410 mM) stimulated adenylyl cyclase. Further studies showed however that this conclusion was erroneous and due to the fact that Ap n As recognized the antibody directed against cyclic AMP and interfered with the assay. When adenylyl cyclase activity was measured from the conversion of [ 3 H]-ATP into [ 3 H]-cyclic AMP, no stimulatory activity of Ap n As could be detected. We also observed that in contrast to ADP, Ap n As (0.1 mM) did not inhibit forskolin stimulated adenylyl cyclase activity. Finally, we checked that Ap n As (0.1 mM) did not inhibit ADP-induced inhibition of forskolin-stimulated adenylyl cyclase (data not shown). These results indicated that Ap n As are neither agonists nor antagonists of the G i -coupled ADP receptor.
Discussion
This paper ®rst shows that Ap n As are not agonists of endogenous P2Y 1 and P2Y 2 receptors in endothelial cell clones. Weak actions of Ap 3 A and Ap 6 A were observed but they were likely due to low amounts of contaminating ADP. The lack of clear agonist action of Ap n As was surprising. Ap 3 A and Ap 4 A have been reported to stimulate recombinant P2Y 1 and P2Y 2 receptors as well as the endogenous P2Y 1 receptors in ECV305 endothelial cells (Lazarowski et al., 1995; Schachter et al., 1996; Mateo et al., 1996; Stachon et al., 1998; Conant et al., 1998) . Our results are however in agreement with previous reports indicating no action of Ap 4 A on other endogenous P2Y 2 receptors (Chen et al., 1996; Conant et al., 1998; Mateo et al., 1996) . Reasons for these dierences are discussed below.
A second observation of this paper is that Ap 4 A, Ap 5 A and Ap 6 A inhibit ADP responses in B10 cells. Knowing that ADP responses in these cells are sensitive to PPADS (Vigne et al., 1998a,b) , A2P5P and A3P5P (Hechler et al., 1998a) and that these cells only express mRNA species that code for P2Y 1 receptors (Webb et al., 1996) , an obvious conclusion is that Ap 4 A, Ap 5 A and Ap 6 A inhibit P2Y 1 receptors. This conclusion is consistent with the results of experiments using platelets. Ap 4 A, Ap 5 A and Ap 6 A have been reported to prevent platelet aggregation to ADP (Harrison et al., 1975) . Ap 5 A was further described as a competitive antagonist of ADP-induced rises in [Ca 2+ ] i in human platelets (Hall & Hourani, 1993) . This action was initially attributed to the platelet P 2T receptor. It is now known to be mediated by P2Y 1 receptors Fagura et al., 1998; Hechler et al., 1998a; Jin et al., 1998) .
A recent paper (King et al., 1999) established that diinosine polyphosphates but not Ap n As were antagonists at P2X 1 and P2X 3 receptors. It would be of interest to test the possibility that Ap n As are deaminated by endothelial cells and that actions of Ap n As are in fact mediated by the corresponding diinosine polyphosphates.
We have previously described that ATP is a natural antagonist of the endogenous P2Y 1 receptor in B10 cells. The K i value for ATP is 23 mM (Hechler et al., 1998b) . Ap 4 A and Ap 5 A are slightly more potent than ATP with apparent K i values of 6 ± 10 mM. These values clearly rule out the possibility that the observed antagonistic actions were mediated by contaminating ATP. Ap 6 A is less potent than ATP. Synthetic antagonists of the endogenous P2Y 1 receptor in B10 cells have previously been described. These are 2-chloro-ATP (K i =27 mM), 2-methylthio-ATP (K i =36 mM), benzoylATP (K i =5 mM), A2P5P (K i =5 mM) and A3P5P (K i =3 mM) (Hechler et al., 1998a,b; Vigne et al., 1999) . Ap 4 A is thus as potent as adenosine biphosphates.
These results indicate that Ap n As (n=4 ± 6) are antagonists of the endogenous P2Y 1 receptor in B7 in B10 cells and in platelets. They are agonists of P2Y 1 receptors expressed in recombinant expression systems (see Introduction). Similar discrepancies have already been noticed with ATP (Hechler et al., 1998b; Palmer et al., 1998) , benzoyl ATP Vigne et al., 1999) , A2P5P, A3P5P and their sulphate derivatives Hechler et al., 1998a; Jin et al., 1998) . One possibility could be that many adenine nucleotides (except ADP and 2-methylthio-ADP) are in fact partial agonists of P2Y 1 receptors and that receptor densities determine whether nucleotides have agonist or antagonist properties (Palmer et al., 1998 ). An agonist activity may prevail in the presence of a large receptor reserve. An antagonist activity may prevail at low receptor densities. This hypothesis cannot be tested in the absence of suitable radioligands to titrate receptors.
Another proposed action of adenine nucleotides in B10 cells is to inhibit adenylyl cyclase (Webb et al., 1996) . This paper shows that Ap n As have no action (either stimulatory or inhibitory) on adenylyl cyclase in B10 cells. This suggested that Ap n As do not recognise the G i -coupled, ADP receptor in B10 cells. Thus it may be concluded that ADP recognises two types of receptors in B10 cells (i) a [Ca 2+ ] i coupled receptor which is Figure 5 Actions of Ap n As in B7 cells in B10 cells. (A) Indo-1 loaded cells were incubated in the presence of 0.1 mM Ap n As or of 1 mM UTP and 0.1 mM Ap n As and mean indo-1¯uorescence ratio were recorded at 10 s. Increases in indo-1¯uorescence ratio were expressed relative to that produced by 0.1 mM UTP. (B) Concentration-response curves for the actions of Ap 4 A on ADP (1 mM) and UTP (0.1 mM) responses. *P50.05 and **P50.01 as compared to controls. n on the abscissa means the number of phosphate groups in the Ap n As tested. Means+s.e.mean (n=3) are shown.
sensitive to Ap n As and (ii) a Gi-coupled receptor which is insensitive to Ap n As. A similar conclusion was drawn previously from studies using PPADS, A2P5P and A3P5P. These compounds inhibit ADP-induced intracellular Ca 2+ mobilization in B10 cells. They do not inhibit ADP-induced inhibition of adenylyl cyclase (Webb et al., 1996; Hechler et al., 1998a) .
In conclusion, this study indicates that all actions of Ap n As in B7 and B10 cells can be accounted for by the endogenous P2Y 1 receptors. Ap 4 A, Ap 5 A and Ap 6 A are antagonists of this receptor.
